TrialJournal of acquired immune deficiency syndromes (1999)2010

Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study.

Jose M Gatell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.